Heterodimeric Bispecific Single Chain Variable Fragments (scFv) Killer Engagers (BiKEs) Enhance NK-cell Activity Against CD133+ Colorectal Cancer Cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Heterodimeric Bispecific Single Chain Variable Fragments (scFv) Killer Engagers (BiKEs) Enhance NK-cell Activity Against CD133+ Colorectal Cancer Cells
Authors
Keywords
Cancer Stem Cell, Immunological Synapse, Bispecific Antibody, Phage Display Library, CD107a Expression
Journal
Targeted Oncology
Volume 11, Issue 3, Pages 353-361
Publisher
Springer Nature
Online
2015-11-14
DOI
10.1007/s11523-015-0391-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effective Eradication of Glioblastoma Stem Cells by Local Application of an AC133/CD133-Specific T-cell–Engaging Antibody and CD8 T Cells
- (2015) Shruthi Prasad et al. CANCER RESEARCH
- Heterodimeric Bispecific Single-Chain Variable-Fragment Antibodies Against EpCAM and CD16 Induce Effective Antibody-Dependent Cellular Cytotoxicity Against Human Carcinoma Cells
- (2013) Daniel A. Vallera et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Cytokine-induced killer (CIK) cells bound with anti-CD3/anti-CD133 bispecific antibodies target CD133high cancer stem cells in vitro and in vivo
- (2013) Jianhua Huang et al. CLINICAL IMMUNOLOGY
- Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression
- (2013) Amy P.N. Skubitz et al. GYNECOLOGIC ONCOLOGY
- A dual-targeting triplebody mediates preferential redirected lysis of antigen double-positive over single-positive leukemic cells
- (2013) Ingo Schubert et al. mAbs
- T and NK cells of B cell NHL patients exert cytotoxicity against lymphoma cells following binding of bispecific tetravalent antibody CD19 × CD3 or CD19 × CD16
- (2012) Lisa M. Pörtner et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Bispecific and Trispecific Killer Cell Engagers Directly Activate Human NK Cells through CD16 Signaling and Induce Cytotoxicity and Cytokine Production
- (2012) M. K. Gleason et al. MOLECULAR CANCER THERAPEUTICS
- Identification and characterization of a novel scFv recognizing human and mouse CD133
- (2012) Suresh Kumar Swaminathan et al. Drug Delivery and Translational Research
- Immunotoxin targeting CD133+ breast carcinoma cells
- (2012) John R. Ohlfest et al. Drug Delivery and Translational Research
- Construction and humanization of a functional bispecific EGFR × CD16 diabody using a refolding system
- (2011) Ryutaro Asano et al. FEBS Journal
- Targeting Tumor-Initiating Cancer Cells with dCD133KDEL Shows Impressive Tumor Reductions in a Xenotransplant Model of Human Head and Neck Cancer
- (2011) N. N. Waldron et al. MOLECULAR CANCER THERAPEUTICS
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
- Novel conjugates of single-chain Fv antibody fragments specific for stem cell antigen CD123 mediate potent death of acute myeloid leukaemia cells
- (2010) Christoph Stein et al. BRITISH JOURNAL OF HAEMATOLOGY
- Pancreatic Cancer Cells Resistant to Chemoradiotherapy Rich in “Stem-Cell-Like” Tumor Cells
- (2010) Zhiyong Du et al. DIGESTIVE DISEASES AND SCIENCES
- Identification of a novel monoclonal antibody recognizing CD133
- (2010) Suresh Kumar Swaminathan et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Effective Elimination of Acute Myeloid Leukemic Cells by Recombinant Bispecific Antibody Derivatives Directed Against CD33 and CD16
- (2010) Heiko Singer et al. JOURNAL OF IMMUNOTHERAPY
- Therapeutic implications of colon cancer stem cells
- (2010) Eros Fabrizi WORLD JOURNAL OF GASTROENTEROLOGY
- CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers
- (2008) L M Smith et al. BRITISH JOURNAL OF CANCER
- Ultrastructural characterization of CD133+stem cells bound to superparamagnetic nanoparticles: possible biotechnological applications
- (2008) L. F. PAVON et al. JOURNAL OF MICROSCOPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started